Paul Mésange

425 total citations
12 papers, 224 citations indexed

About

Paul Mésange is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Paul Mésange has authored 12 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Paul Mésange's work include Cancer Treatment and Pharmacology (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Paul Mésange is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Paul Mésange collaborates with scholars based in France, Brazil and Austria. Paul Mésange's co-authors include Annette K. Larsen, Alexandre E. Escargueil, Aimery de Gramont, Michèle Sabbah, Virginie Poindessous, Laure Aurelian, Toshie Saito, Linh P. Nguyen, Marlene Rabinovitch and Desmond J. Fitzgerald and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Clinical Cancer Research.

In The Last Decade

Paul Mésange

11 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Mésange France 6 91 89 68 45 32 12 224
Kaijian Lei China 9 108 1.2× 71 0.8× 90 1.3× 23 0.5× 15 0.5× 38 294
Yibo Cai China 10 76 0.8× 55 0.6× 169 2.5× 34 0.8× 29 0.9× 19 295
Yueyun Chen China 9 71 0.8× 108 1.2× 170 2.5× 57 1.3× 62 1.9× 27 301
Feiying Gu China 10 133 1.5× 94 1.1× 106 1.6× 55 1.2× 54 1.7× 11 316
Massimiliano Grassi Italy 9 81 0.9× 101 1.1× 120 1.8× 66 1.5× 62 1.9× 23 290
Hannah V. Woodcock United Kingdom 4 113 1.2× 166 1.9× 26 0.4× 30 0.7× 13 0.4× 10 290
Miho Okano Japan 7 134 1.5× 66 0.7× 138 2.0× 87 1.9× 16 0.5× 24 278
Bérengère Renault Switzerland 7 139 1.5× 159 1.8× 25 0.4× 19 0.4× 41 1.3× 9 328
Bin Fan China 9 88 1.0× 103 1.2× 30 0.4× 87 1.9× 16 0.5× 18 219

Countries citing papers authored by Paul Mésange

Since Specialization
Citations

This map shows the geographic impact of Paul Mésange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Mésange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Mésange more than expected).

Fields of papers citing papers by Paul Mésange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Mésange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Mésange. The network helps show where Paul Mésange may publish in the future.

Co-authorship network of co-authors of Paul Mésange

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Mésange. A scholar is included among the top collaborators of Paul Mésange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Mésange. Paul Mésange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tamošiūnienė, Rasa, Paul Mésange, Toshie Saito, et al.. (2018). Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension. Circulation Research. 122(12). 1689–1702. 100 indexed citations
2.
Mésange, Paul, Nathalie Ferrand, Michèle Sabbah, et al.. (2018). Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clinical Cancer Research. 24(11). 2548–2558. 14 indexed citations
3.
Larsen, Annette K., Stephan G. Klinz, Ashish Kalra, et al.. (2018). Influence of liposomal irinotecan (nal-IRI) and non-liposomal irinotecan, alone and in combination, on tumor growth and angiogenesis in colorectal cancer (CRC) models.. Journal of Clinical Oncology. 36(4_suppl). 711–711. 4 indexed citations
4.
Mésange, Paul, Mouna Ayadi, Marielle Chiron, et al.. (2015). P-221 Acquired 5-FU resistance in CRC models is accompanied by upregulation of VEGF-VEGFR1 signaling, increased migration and invasion that can be attenuated by aflibercept. Annals of Oncology. 26. iv64–iv64. 1 indexed citations
5.
6.
Mésange, Paul, Mira Ayadi, Virginie Poindessous, et al.. (2014). 406 Aflibercept (Zaltrap) directly attenuates the migration and invasion of colorectal cancer cells. European Journal of Cancer. 50. 130–130. 1 indexed citations
7.
Chibaudel, Benoist, Christophe Tournigand, Benoît Samson, et al.. (2014). Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study. Annals of Oncology. 25. iv167–iv167. 9 indexed citations
8.
9.
10.
11.
Bordin, Diana L., Guido Lenz, Jenifer Saffi, et al.. (2013). DNA alkylation damage and autophagy induction. Mutation Research/Reviews in Mutation Research. 753(2). 91–99. 31 indexed citations
12.
Larsen, Annette K., et al.. (2013). Functions and Clinical Implications of Autocrine VEGF Signaling in Colorectal Cancer. Current Colorectal Cancer Reports. 9(3). 270–277. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaijian Lei Breakdown of academic impact, for papers by Yibo Cai Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by Feiying Gu Breakdown of academic impact, for papers by Massimiliano Grassi Breakdown of academic impact, for papers by Hannah V. Woodcock Breakdown of academic impact, for papers by Miho Okano Breakdown of academic impact, for papers by Bérengère Renault Breakdown of academic impact, for papers by Bin Fan
Rankless by CCL
2026